Abstract：
OBJECTIVE: Sacrocolpopexy (SCP) is the gold standard surgical management of apical pelvic organ prolapse (POP), and increasingly, minimally invasive SCP is being adopted as a primary treatment for advanced uterovaginal prolapse. Patients undergoing surgery for POP consider postoperative improvement in sexual function to be a highly important outcome, and sexual dysfunction and dyspareunia severe adverse events. Therefore, it is crucial to understand the impact of minimally invasive SCP on postoperative sexual function. We aimed to analyze the current literature available to discuss the impact of minimally invasive SCP on postoperative sexual function.
METHODS: We performed a narrative review of minimally invasive SCP and its impact on sexual function. PubMed and EMBASE were searched from inception through 28 January 2024 for studies that reported sexual function following surgery for POP. Baseline and postoperative sexual activity, dyspareunia, and validated questionnaire scores for sexual function were documented.
RESULTS: Minimally invasive SCP is associated with improved postoperative sexual function, increased rates of postoperative sexual activity, and low rates of dyspareunia. Dyspareunia was not associated with mesh related complications. Patients with baseline dyspareunia or pain were more likely to experience persistent dyspareunia after surgery.
CONCLUSIONS: The rates of POP are increasing in our aging population, and sexual function is very important to patients undergoing surgery for POP. Clinicians should consider all factors related to sexual function when planning surgery for POP and address dyspareunia prior to surgery. Sexual function appears to improve overall after minimally invasive SCP and de novo dyspareunia rates are low.
METHODS: We performed a narrative review of minimally invasive SCP and its impact on sexual function. PubMed and EMBASE were searched from inception through 28 January 2024 for studies that reported sexual function following surgery for POP. Baseline and postoperative sexual activity, dyspareunia, and validated questionnaire scores for sexual function were documented.
RESULTS: Minimally invasive SCP is associated with improved postoperative sexual function, increased rates of postoperative sexual activity, and low rates of dyspareunia. Dyspareunia was not associated with mesh related complications. Patients with baseline dyspareunia or pain were more likely to experience persistent dyspareunia after surgery.
CONCLUSIONS: The rates of POP are increasing in our aging population, and sexual function is very important to patients undergoing surgery for POP. Clinicians should consider all factors related to sexual function when planning surgery for POP and address dyspareunia prior to surgery. Sexual function appears to improve overall after minimally invasive SCP and de novo dyspareunia rates are low.
摘要：
目的：膀胱切除术(SCP)是治疗盆腔顶端器官脱垂(POP)的金标准。而且越来越多,目前正在采用微创SCP作为晚期子宫阴道脱垂的主要治疗方法。接受POP手术的患者认为术后性功能的改善是非常重要的结果，性功能障碍和性交困难严重不良事件。因此,了解微创SCP对术后性功能的影响至关重要。我们旨在分析现有文献，以讨论微创SCP对术后性功能的影响。
方法：我们对微创SCP及其对性功能的影响进行了叙述性综述。从研究开始到2024年1月28日，对PubMed和EMBASE进行了搜索，以寻找报告POP手术后性功能的研究。基线和术后性活动，性交困难,并记录了经过验证的性功能问卷评分.
结果：微创SCP与术后性功能改善有关，术后性活动率增加，性交困难的发生率很低。呼吸困难与网片相关并发症无关。有基线性交困难或疼痛的患者更有可能在手术后经历持续性性交困难。
结论：在我们的老龄化人口中，持久性有机污染物的发生率正在增加，性功能对POP手术患者非常重要。临床医生在计划POP手术时应考虑与性功能有关的所有因素，并在手术前解决性交困难。微创SCP后，性功能似乎总体上有所改善，并且新发性交困难发生率较低。
方法：我们对微创SCP及其对性功能的影响进行了叙述性综述。从研究开始到2024年1月28日，对PubMed和EMBASE进行了搜索，以寻找报告POP手术后性功能的研究。基线和术后性活动，性交困难,并记录了经过验证的性功能问卷评分.
结果：微创SCP与术后性功能改善有关，术后性活动率增加，性交困难的发生率很低。呼吸困难与网片相关并发症无关。有基线性交困难或疼痛的患者更有可能在手术后经历持续性性交困难。
结论：在我们的老龄化人口中，持久性有机污染物的发生率正在增加，性功能对POP手术患者非常重要。临床医生在计划POP手术时应考虑与性功能有关的所有因素，并在手术前解决性交困难。微创SCP后，性功能似乎总体上有所改善，并且新发性交困难发生率较低。
